Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 22, Number 12—December 2016
Dispatch

Evaluating Healthcare Claims for Neurocysticercosis by Using All-Payer All-Claims Data, Oregon, 2010–2013

Robert H. FleckerComments to Author , Seth E. O’Neal, and John M. Townes
Author affiliations: Oregon Health & Science University, Portland, Oregon, USA

Main Article

Table

Diagnostic codes in healthcare claims from persons with neurocysticercosis (cases) versus age- and sex-matched controls, Oregon, 2010–2013

Diagnostic code group No. (%) cases, n = 125 No. (%) controls, n = 500 Odds ratio (95% CI)
Meningitis/encephalitis 5 (4.0) 1 (0.2) 20.0 (2.3–171.2)
Seizure 41 (32.8) 19 (3.8) 13.3 (6.8–25.9)
Stroke 17 (13.6) 16 (3.2) 5.6 (2.5–12.4)
Headache 63 (50.4) 120 (24.0) 3.2 (2.1–4.8)
Cognitive disorder 11 (8.8) 16 (3.2) 3.1 (1.4–7.1)
Syncope 12 (9.6) 25 (5.0 2.0 (1.0–4.2)
Psychotic disorder 8 (6.4) 21 (4.2) 1.6 (0.7–3.8)
Anxiety disorder 35 (28.0) 124 (24.8) 1.2 (0.8–1.8)
Mood disorder 32 (25.6) 134 (26.8) 0.9 (0.6–1.5)
Hydrocephalus 7 (5.6) 0 *
Cerebral edema 5 (4.0) 0 *

*Hydrocephalus and cerebral edema were significantly more common among cases. However, the odds ratio could not be calculated because these diagnostic codes did not occur in the control group.

Main Article

Page created: November 18, 2016
Page updated: November 18, 2016
Page reviewed: November 18, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external